Comparison of gene expression profiles altered by comfrey and riddelliine in rat liver
2007

Gene Expression Changes from Comfrey and Riddelliine in Rat Liver

Sample size: 6 publication Evidence: moderate

Author Information

Author(s): Guo Lei, Mei Nan, Dial Stacey, Fuscoe James, Chen Tao

Primary Institution: Division of Systems Toxicology, National Center for Toxicological Research, FDA

Hypothesis

Pyrrolizidine alkaloids (PAs) contained in comfrey are the main active components responsible for carcinogenicity.

Conclusion

The carcinogenesis-related gene expression patterns resulting from the treatments of comfrey and riddelliine are very similar, indicating that PAs are the main active components responsible for the carcinogenicity of comfrey.

Supporting Evidence

  • Comfrey has been used for over 2000 years but is known to be hepatotoxic and carcinogenic.
  • The study found that both comfrey and riddelliine altered gene expressions related to cancer.
  • A total of 1814 genes were altered by comfrey treatment, compared to 639 by riddelliine.

Takeaway

This study looked at how two substances, comfrey and riddelliine, affect genes in rat livers. It found that both can change similar genes that are linked to cancer.

Methodology

Rats were treated with either comfrey or riddelliine for 12 weeks, and gene expression was analyzed using microarrays.

Limitations

The study does not clarify the specific mechanisms of tumor induction by comfrey due to its complex mixture of substances.

Participant Demographics

Big Blue Fisher 344 rats were used in the study.

Statistical Information

P-Value

p<0.01

Statistical Significance

p<0.01

Digital Object Identifier (DOI)

10.1186/1471-2105-8-S7-S22

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication